Healthcare

BTC Health Ltd (ASX:BTC)

Industry Group : Diversified Financials | Industry Group Name : Diversified Financial Services

Market Price : AUD 0.0850.002 (2.41%)

(as on 2021-09-28 09:55:14)

Market Cap : AUD 23.957 M

Previous Close Open Close* Day Range 52 WEEK HIGH LOW
0.083 0.083 0.085 0.083L 0.085 H 0.067L 0.195 H
Last Trade 0.085
Change% 2.4096
52 W H/L 0.195/0.067
EBITDA -397,543
NPAT After Abnormal Items -391,686
Equity 10.837 M
ROE% -3.61%
Total Liabilities 2.147 M
Total Revenue 18,333
Cash and Cash Equivalents 2.369 M

Stock Information

Share price 0.085
Market Cap 23.957 M
Price/Gross Cash Flow -66.28
Dividend Yield Excluding Special 0.00%
Ending Shares 246.132 M
52-Week Range 0.067-0.195
P/E ratio 0.000
Sector P/E --
EPS -0.16
EV/EBITDA --
Net Profit Margin (%) -2,937.72%
Gross Cash Flows Per Share -0.00
Net Gearing -21.86%
Gross DPS (AUD) 0
Gross Dividend Yield (Annualized) 0.00%
Earnings Yield 0.000
Net Tangible Asset (NTA) 0.04
Sales Per Share 0.00
Book Value Per Share 0.04

Announcements

Heading Date/Time
Net Tangible Asset Backing - August 2021  09/09/2021 10:09AM
BTC Shareholder Update - September 2021  03/09/2021 9:23AM
Change of Director's Interest Notice - Bruce Hewett  18/08/2021 3:42PM
Application for quotation of securities - BTC  18/08/2021 3:17PM
Appendix 4G  17/08/2021 5:24PM
Appendix 4E & Annual Report - 30 June 2021  17/08/2021 5:24PM
Net Tangible Asset Backing - 31 July 2021  05/08/2021 7:06PM
Cleansing Notice - Placement of Shares  14/07/2021 8:25AM
Becoming a substantial holder  13/07/2021 4:04PM
Net Tangible Asset Backing - 30 June 2021  09/07/2021 2:02PM
Proposed issue of securities - BTC  02/07/2021 12:00PM
$2.5m capital raise to fund exclusive distribution rights  02/07/2021 11:59AM
BTC investment opportunity - Mannitol portfolio  01/07/2021 8:58AM
Trading Halt  30/06/2021 7:32PM
Exclusive distribution rights for Bronchitol & Aridol  30/06/2021 7:24PM
Net Tangible Asset Backing - 31 May 2021  04/06/2021 5:21PM
Net Tangible Asset Backing - 30 April 2021  07/05/2021 9:10AM
Quarterly business update - 31 March 2021  19/04/2021 3:30PM
Net Tangible Asset Backing - 31 March 2021  08/04/2021 8:23AM
Change in substantial holding  15/03/2021 3:23PM
Net Tangible Asset Backing - 28 February 2021  11/03/2021 3:04PM
Change of Director's Interest Notice - Richard Treagus  01/03/2021 8:13AM
Change in substantial holding  24/02/2021 4:44PM
BTC secures exclusive distribution rights for NEOLA from GPX  22/02/2021 9:05AM
Half-year result and business update - 31 December 2020  16/02/2021 4:40PM
Half-Year Financial Report & Appendix 4D - 31 December 2020  16/02/2021 4:38PM
Net Tangible Asset Backing - 31 January 2021  10/02/2021 10:30AM
Ceasing to be a substantial holder  28/01/2021 3:59PM
Change in substantial holding  25/01/2021 3:09PM

Similar Companies

Related Articles

About Company

Headquartered in Melbourne, Australia, BTC health Ltd (ASX: BTC) provides development capital and management expertise to fast-growing Australian biotech, medtech and pharmaceutical companies. The company also delivers exceptional partnering, product development and commercialisation capabilities across the Asia-Pacific region.

Corporate Information

company address Level 1, 10 Oxley Road, HAWTHORN, VIC, AUSTRALIA, 3122

company phone1800100282

company websitehttp://www.btchealth.com.au

Dividends

Ex-Dividend Date Franking DPS (AUD) Dividend Yield
30/06/2021 -- 0.000 0.00%
30/06/2020 -- 0.000 0.00%
30/06/2019 -- 0.000 0.00%
30/06/2018 -- 0.000 0.00%
30/06/2017 -- 0.000 0.00%
30/06/2016 -- 0.000 0.00%
30/06/2015 -- 0.000 0.00%
30/06/2014 -- 0.000 0.00%
30/06/2013 0% 0.010 50.00%
30/06/2012 -- 0.000 0.00%

Event Calendar

Event Type Event Date Event Year
Report (Annual) 2022-08-16 2022
Report (Prelim) 2022-08-16 2022
Report (Interim) 2022-02-15 2022

Financials

Breakdown 30/06/2021 30/06/2020 30/06/2019 30/06/2018 30/06/2017
Trading Revenue 13,333 160,000 170,000 40,000 --
Other Revenue 5,000 125,000 130,000 144,900 11,088
Total Revenue 18,333 285,000 300,000 184,900 11,088
Interest Income 857 9,604 17,763 22,937 17,408
Interest Expenses 0 0 0 0 0
Expenses -410,876 -577,640 -1.011 M -1.396 M -545,023
EBITDA -392,543 -292,640 -710,505 -1.211 M -533,935
Depreciation and Amortization 0 0 0 0 0
Depreciation 0 0 0 0 0
Amortisation 0 0 0 0 0
EBIT -392,543 -292,640 -710,505 -1.211 M -533,935
Pre Tax Profit -391,686 -283,036 -692,742 -1.188 M -516,527
Tax Expense 0 0 0 0 0
Net Profit After Tax -391,686 -283,036 -692,742 -1.188 M -516,527
Minority Interest 0 0 0 0 0
Preference Dividend 0 0 0 0 0
Net Abnormal Items 0 0 0 -280,000 0
Reported Net Profit After Abnormal Items -391,686 -283,036 -692,742 -1.468 M -516,527
Ending Shares 246.132 M 246.132 M 244.543 M 130.927 M 127.108 M
Weighted Average Shares 246.132 M 245.738 M 134.946 M 128.977 M 114.568 M
EPS After Abnormal Items (cents) -0.16 -0.12 -0.51 -1.14 -0.45
Breakdown 30/06/2021 30/06/2020 30/06/2019 30/06/2018 30/06/2017
Total Current Assets 4.984 M 3.358 M 4.107 M 2.733 M 3.108 M
Total Non Current Assets 8 M 8.099 M 7.613 M 582,085 1.559 M
Total Assets 12.984 M 11.457 M 11.719 M 3.315 M 4.667 M
Total Current Liabilities 2.147 M 228,136 377,866 342,431 688,437
Total Non Current Liabilities 0 0 0 0 0
Total Liabilities 2.147 M 228,136 377,866 342,431 688,437
Net Assets 10.837 M 11.229 M 11.341 M 2.973 M 3.979 M
Breakdown 30/06/2021 30/06/2020 30/06/2019 30/06/2018 30/06/2017
Net Operating Cash -366,152 -492,023 -623,682 -555,524 -388,366
Net Invested Cash -15,162 -861,366 -6.933 M 118,940 2,132
Net Financing Cash Flows 0 160,757 8.85 M 0 2.287 M
End Cash Position 2.369 M 2.75 M 3.943 M 2.65 M 3.086 M
Beginning Cash 2.75 M 3.943 M 2.65 M 3.086 M 1.185 M
Exchange Rate Adjustments 0 0 0 0 0
Other Cash Adjustments 0 0 0 0 0
Ending Cash 2.369 M 2.75 M 3.943 M 2.65 M 3.086 M

© 2021 Morningstar, Inc. All rights reserved. Neither Morningstar, its affiliates, nor the content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice or ‘regulated financial advice’ under New Zealand law has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Ltd, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. For more information refer to our Financial Services Guide (AU) and Financial Advice Provider Disclosure Statement (NZ) at www.morningstar.com.au/s/fsg.pdf and www.morningstar.com.au/s/fapds.pdf. You should consider the advice in light of these matters and if applicable, the relevant Product Disclosure Statement before making any decision to invest. Our publications, ratings and products should be viewed as an additional investment resource, not as your sole source of information. Past performance does not necessarily indicate a financial product’s future performance. To obtain advice tailored to your situation, contact a professional financial adviser. Some material is copyright and published under license from ASX Operations Pty Ltd ACN 004 523 782.

We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it. OK